News
NIH and Exothera in partnership to produce COVID-19 vaccine
The National Institutes of Health (NIH) – the US’s medical research agency – has selected Exothera to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2 (COVID-19).